Healthcare Services

Global Non-invasive Prenatal Testing Market Forecast 2026–2035: Long-Term Growth Insights

February 27, 2026April 15, 2026 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the non-invasive prenatal testing market from 2026–2035 with trusted insights from The Business Research Company

How is the Non-invasive Prenatal Testing Market size predicted to change over the forecast window of 2026–2035?

The market size for non-invasive prenatal testing has expanded quickly over recent years. This market is anticipated to expand from $6.27 billion in 2025 to $7.21 billion by 2026, achieving a compound annual growth rate (CAGR) of 15.0%. Factors contributing to its historical growth include heightened awareness of prenatal screening, the dependence on invasive diagnostic approaches, a rise in the application of assay kits and reagents, the integration of next-generation sequencing in lab settings, and the necessity for promptly identifying chromosomal abnormalities.

The non-invasive prenatal testing market is projected to experience substantial expansion in the coming years. This market is anticipated to reach $12.37 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 14.4%. Factors contributing to this growth over the forecast period include the worldwide increase in the uptake of non-invasive prenatal testing, greater investment in sophisticated sequencing technologies, the broadening of hospital and diagnostic laboratory infrastructures, a heightened need for early genetic screening, and the progressive incorporation of AI and data analytics into prenatal diagnostics. Key trends anticipated during this period encompass the growing adoption of AI-driven genetic analysis, an expanding application of NGS and PCR systems for prenatal testing, the increasing establishment of cloud-based data management solutions in diagnostics, wider deployment of high-throughput screening technologies, and the progressive integration of personalized prenatal risk assessment methodologies.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=2492&type=smp

Which Drivers Are Contributing To The Expansion Of The Non-invasive Prenatal Testing Market?

The non-invasive prenatal testing market is projected to expand due to the rising maternal age. This increase in maternal age is influenced by various factors, including the pursuit of education and careers, achieving financial stability, personal preferences, delayed marriage, advancements in contraception, and evolving societal norms, which empower women to make more deliberate choices regarding family planning. As women postpone childbirth, the likelihood of chromosomal abnormalities increases, prompting more pregnant individuals to opt for NIPT to evaluate the well-being of their pregnancies. For instance, in March 2025, according to the Centers for Disease Control and Prevention, a US-based government agency, the average age of mothers at their first birth rose to 27.5 years in 2023, up from 27.4 in 2022, marking yet another record high for the nation. Consequently, the growing maternal age will continue to stimulate the expansion of the non-invasive prenatal testing market.

What Segment Categories Are Covered In The Non-invasive Prenatal Testing Market?

The non-invasive prenatal testing market covered in this report is segmented –

1) By Type: Consumables, Instruments

2) By Application: Trisomy, Microdeletion, Genetics, Rh factor

3) By End User: Hospital, Diagnostic Labs

Subsegments:

1) By Consumables: Assay Kits, Reagents, Disposables

2) By Instruments: Next-Generation Sequencers (NGS), Polymerase Chain Reaction (PCR) Systems, Ultrasound Devices

What Long-Term Trends Are Expected To Shape The Future Of The Non-invasive Prenatal Testing Market?

Companies operating within the non-invasive prenatal testing (NIPT) market are prioritizing the creation of advanced solutions, specifically linked-SNP (single nucleotide polymorphism) technology, to boost diagnostic accuracy, enhance the detection of complex genetic cases, and reduce dependence on paternal samples. This linked-SNP technology functions by assessing single-gene variants through the analysis of genetically linked markers across the genome to deduce inheritance patterns, facilitating more precise identification of challenging conditions such as homozygous mutations. As an illustration, in August 2025, Natera, a US-based cell-free DNA (cfDNA) testing and precision medicine firm, unveiled Fetal Focus, an NIPT for inherited single-gene disorders that directly screens the fetus using only maternal blood when the biological father is not available. The test targets five genes: CFTR, SMN1, HBA1/HBA2, and HBB, and is backed by data from the EXPAND clinical trial. Its initial findings (n=101) indicated 91% sensitivity and successfully identified all five homozygous variant fetuses, highlighting the efficacy of its linked-SNP–based methodology in providing noninvasive and clinically relevant risk assessment.

Which Major Industry Participants Are Leading The Non-invasive Prenatal Testing Market Growth?

Major companies operating in the non-invasive prenatal testing market are F. Hoffmann-La Roche AG, Illumina Inc., Laboratory Corporation of America Holdings, Natera Inc., PerkinElmer Inc., Quest Diagnostics Inc., Agilent Technologies Inc., BGI Diagnosis Co Ltd., Berry Genomics Co, LifeCodexx AG, Myriad Genetics Inc., NIPD Genetics Co Ltd., Sequenom Inc., Annoroad Gene Technology Co Ltd., Centogene AG, Counsyl Inc., EUROFINS Genoma Group, Eurofins Scientific SE, Next Biosciences, Premaitha Health Plc, Ariosa Diagnostics Inc., Yourgene Health PLC, GE Healthcare Technologies Inc., Koninklijke Philips NV, Thermo Fisher Scientific Inc., Pacific Biosciences of California Inc., QIAGEN NV, MedGenome Labs Ltd., Progenity Inc., Beijing Genomics Institute

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/non-invasive-prenatal-testing-global-market-report

Which Geographic Areas Are Emerging As Strong Markets For The Non-invasive Prenatal Testing Market?

North America was the largest region in the non-invasive prenatal testing market in 2025. Western Europe was the second largest region in the non-invasive prenatal testing market. The regions covered in the non-invasive prenatal testing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Non-invasive Prenatal Testing Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=2492&type=smp

Browse Through More Reports Similar to the Global Non-invasive Prenatal Testing Market 2026, By The Business Research Company

Pregnancy Test Kits Market Report 2026

https://www.thebusinessresearchcompany.com/report/pregnancy-test-kits-global-market-report

Prenatal Testing And Newborn Screening Market Report 2026

https://www.thebusinessresearchcompany.com/report/prenatal-testing-and-newborn-screening-global-market-report

Prenatal And Newborn Genetic Testing Market Report 2026

https://www.thebusinessresearchcompany.com/report/prenatal-and-newborn-genetic-testing-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795